Use of VEGF antagonists in the treatment of choroidal retinal neovascularization and permeability disorders in pediatric patients

摘要

The present invention relates to the use of VEGF antagonists in the treatment of pediatric chorioretinal neovascularization or permeability disorders. In particular, the invention relates to a method of treating a child with CNV or ME for use in a method comprising administering to a child's eye a VEGF antagonist that does not enter the systemic circulation or is rapidly cleared. I will provide a. The VEGF antagonist may be administered intravitreally, for example by injection, or topically, for example in the form of eye drops. The present invention further provides the use of a VEGF antagonist in the manufacture of a medicament for treating a child with a chorioretinal neovascular disorder or permeability disorder.